Sort
53,477 grants matching “addiction”
Center for Dissemination and Implementation At Stanford (C-DIAS)
$2,737,561Mark P. McGovern · Stanford University · P50 · FY2023 · DA
UNIVERSITY OF TEXAS SPORE IN LUNG CANCER
$2,736,355University Of Texas Sw Med Ctr/Dallas · P50 · FY2002 · CA
Center for Dissemination and Implementation At Stanford (C-DIAS)
$2,736,209Mark P. McGovern · Stanford University · P50 · FY2024 · DA
Chicago WIHS Consortium V (CWC)
$2,735,923Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2018 · AI
Center for Dissemination and Implementation At Stanford (C-DIAS)
$2,734,809Mark P. McGovern · Stanford University · P50 · FY2025 · DA
Dnmt3a as an epigenetic target for chronic pain treatment
$2,728,155Zhizhong Z Pan · University Of Tx Md Anderson Can Ctr · RF1 · FY2019 · NS
High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
$2,727,763Bryan L McLaughlin · Micro-Leads, Inc. · U44 · FY2020 · NS
Helping to End Addiction Long-term (HEAL): Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose
$2,726,004Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
High throughput mapping of neuronal circuitry using DNA sequencing
$2,723,622Anthony M Zador · Cold Spring Harbor Laboratory · RF1 · FY2017 · MH
Research Support Core - Outcomes of Babies with Opioid Exposure (OBOE)
$2,719,629Carla M Bann · Research Triangle Institute · PL1 · FY2019 · HD
Frontal Striatal Systems and Dopamine in Normal and Pathological Behavior
$2,713,014Bruno Averbeck · National Institute Of Mental Health · ZIA · FY2024 · MH
NIDA CENTER FOR GENETIC STUDIES. MARCH 14, 2025 - MARCH 13, 2026. N01DA-23-7787. TASK ORDER 75N95025F00001 (TO3).
$2,712,503Infinity Biologix, Llc · N01 · FY2025 · DA
Center for Addiction and Disease Risk Exacerbation
$2,711,586Peter M. Monti · Brown University · P20 · FY2019 · GM
RCMI@Morgan: Center for Urban Health Disparities Research and Innovation
$2,709,359Paul B Tchounwou · Morgan State University · U54 · FY2023 · MD
Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?
$2,708,839Kyle Matthew Kampman · University Of Pennsylvania · UH3 · FY2024 · DA
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder
$2,708,703Steven M Cohen · Drug Delivery Company, Llc, The · UH3 · FY2025 · DA
Pharmacogenetics of Nicotine Addiction Treatment
$2,705,047Caryn Lerman · University Of Pennsylvania · U01 · FY2011 · DA
Treatment for Complex Patients: Continuing and Extended Care
$2,704,682Joseph R Guydish · University Of California, San Francisco · P50 · FY2012 · DA
RCMI@Morgan: Center for Urban Health Disparities Research and Innovation
$2,703,954Valerie Odero-Marah · Morgan State University · U54 · FY2022 · MD
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder
$2,700,832Steven M Cohen · Drug Delivery Company, Llc, The · UG3 · FY2020 · DA
6/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium Vanderbilt
$2,699,639Laurie E Cutting · Vanderbilt University · U01 · FY2025 · DA
Mouse models of stress disorders and addiction
$2,698,880Andrew Holmes · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
WormBase: a core data resource for C elegans and other nematodes
$2,698,766Paul Warren Sternberg · California Institute Of Technology · P41 · FY2009 · HG
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES
$2,698,607Mary J Kreek · Rockefeller University · P60 · FY2007 · DA
Genomewide Association Study of Cocaine Dependence in two Populations
$2,696,703Joel Gelernter · Yale University · RC2 · FY2009 · DA